Cinacalcet for Secondary Hyperparathyroidism in Patients Receiving HemodialysisGeoffrey A. Block, William G. Goodman, Morrell M. Avram et al.|New England Journal of Medicine|2004Cited by 1.1k
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trialHiddo J.L. Heerspink, Chris Vercammen, Hans‐Henrik Parving et al.|The Lancet|2019Cited by 609